Erythropoeisis-stimulating agents (ESAs) in cervix cancer: The "black box" paradox.
Kamat
Aparna A
AA
Department of Gyncecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, 77030, USA.
Coleman
Robert L
RL
D000740:Anemia / Q000209:etiology / Q000517:prevention & control; D004921:Erythropoietin / Q000627:therapeutic use; D005260:Female; D006397:Hematinics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D011788:Quality of Life; D011994:Recombinant Proteins; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy
D006397:Hematinics; D006454:Hemoglobins; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin; C020622:hemoglobin B